Related Experiment Video
Updated: Aug 6, 2026

04:08
Evaluation of the Effectiveness of Longitudinal Incision for Endoscopic Submucosal Excavation of Gastric Subepithelial Lesions
Published on: April 28, 2026
Successful Endoscopic Submucosal Dissection for Primary Esophageal Mucosa-Associated Lymphoid Tissue Lymphoma
Junya Makiyama1, Hiroko Fukuda2, Kyoko Minamino1,3
1Department of Hematology Sasebo City General Hospital Nagasaki Japan.
DEN Open
|July 17, 2026
Summary
Primary esophageal mucosa-associated lymphoid tissue (MALT) lymphoma is rare. Endoscopic submucosal dissection (ESD) successfully diagnosed and treated a patient with this condition, leading to a complete remission.
Area of Science:
- Gastroenterology
- Oncology
- Pathology
Background:
- Primary esophageal extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) is exceptionally rare.
- Optimal management strategies for esophageal MALT lymphoma remain undefined.
Purpose of the Study:
- To report a case of primary esophageal MALT lymphoma successfully treated with endoscopic submucosal dissection (ESD).
- To evaluate ESD as a potential diagnostic and therapeutic tool for this rare condition.
Main Methods:
- A 70-year-old woman with an incidentally detected esophageal lesion underwent diagnostic workup.
- Endoscopic biopsy was inconclusive; therefore, endoscopic submucosal dissection (ESD) was performed for definitive diagnosis and treatment.
- Histopathological and immunohistochemical analyses confirmed the diagnosis of primary esophageal MALT lymphoma.
Main Results:
- Endoscopic submucosal dissection (ESD) achieved complete resection of the esophageal lesion.
- The patient achieved complete remission and remained disease-free for 3 years post-procedure without further treatment.
- Histopathology confirmed the diagnosis of primary esophageal MALT lymphoma.
Conclusions:
- Endoscopic submucosal dissection (ESD) can be a viable option for both diagnosis and curative treatment of primary esophageal MALT lymphoma.
- This case highlights the potential of minimally invasive endoscopic techniques for managing rare esophageal malignancies.